Click to go to DrugInjuryLaw Home


Legal information and news about prescription drug side effects
Avandia Case Evaluation Tequin Case Evaluation Ortho Evra Case EvaluationKetek Case Evaluation Fosamax Case Evaluation\ Permax Case Evaluation Zelnorm Case Evaluation Vytorin Case Evaluation
Dostinex Case Evaluation Bextra Case Evaluation NuvaRing Case Evalulation Natrecor Case Evaluation Crestor Case Evaluation Vioxx Case EvaluationDigitek Case Evaluation

Medical Device Alert: Medtronic Recalls Sprint Fidelis Heart Lead Wire

Free Case Evaluation

Drug Injury Alerts

Digitek

Digitalis Toxicity • Bradycardia • Low Blood Pressure

Digitek (digoxin tablets) is used in the treatment of congestive heart failure to improve the strength and efficiency of the heart. In April 2008, Actavis Totowa LLC notified healthcare professionals of a Class I nationwide recall of all strengths of Digitek due to the possibility that tablets with double the appropriate thickness may contain twice the approved level of active ingredient.

Read more on our Digitek Information Page >>

Zetia and Vytorin

Drug-Induced Hepatitis • Liver Damage • Liver Failure

Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin) are cholesterol-lowering drugs that selectively inhibit the intestinal absorption of cholesterol. A 2005 Dear Doctor Letter warning of adverse side effects associated with ezetimibe such as liver failure, drug-induced hepatitis, and acute pancreatitis was issued in Canada but not in the US.

Read more on our Zetia and Vytorin Information Page >>

NuvaRing

Heart Attack • Stroke • Blood Clots

NuvaRing is a birth control product in the form of a vaginal ring containing hormones similar to those in oral contraceptives. NuvaRing has been associated with increased risk of blood clots, heart attack, and stroke.

Read more on our NuvaRing Information Page >>

Ortho Evra Patch

Stroke • Blood Clots • Heart Attack

Ortho Evra is a skin adhesive patch used for birth control that can expose women to higher levels of estrogen than regular birth control pills; this can cause serious side effects including heart attacks, strokes, pulmonary embolisms, and blood clots.

Read more on our Ortho Evra Information Page >>

Avandia

Heart Attacks • Strokes

Avandia (rosiglitazone) is in the thiazolidinedione class of drug and is used to treat Type 2 diabetes patients with insulin resistance. In May 2007, it was found that taking Avandia puts patients at a 43% higher risk of heart attacks.

Read more on our Avandia Information Page >>

Permax and Dostinex

Heart Valve Problems • Valvular Heart Disease

Permax (pergolide) and Dostinex (cabergoline) are in the same drug class and used to treat Parkinson's Disease, restless leg syndrome, and migraine headaches. Both Permax and Dostonex have similar warnings for potentially interacting with receptors in the heart valve, causing it to overgrow.

Read more on our Permax and Dostinex Information Page >>

Natrecor

Kidney Damage • Renal Failure

Natrecor (nesiritide) is an intravenous treatment given after heart failure to lessen the symptoms of shortness of breath (dyspnea). Reports of death due to kidney failure following Natrecor treatment have raised safety issues.

Read more on our Natrecor Information Page >>

Drug Injury Watch: Latest Headlines

Visit DrugInjuryWatch.com and see why some of Tom Lamb's articles have been featured on these sites:

    
    

US Supreme Court Might Prohibit Drug Injury Lawsuits

Fosamax

Osteonecrosis of Jaw (ONJ) • Osteomyelitis

Fosamax (alendronate) is used to treat osteoporosis but has been associated with osteonecrosis of the jaw, or jaw bone death. Merck resisted the FDA's request to include a warning label concerning the link for almost a year.

Read more on our Fosamax Information Page >>

Ketek

Liver Failure • Liver Transplant

Ketek (telithromycin) is an antibiotic that has been associated with serious liver problems such as drug-induced hepatitis and liver failure, which can necessitate having a liver transplant.

Read more on our Ketek Information Page >>

Tequin

Coma • Blood Sugar Problems

Tequin (gatifloxacin) is a broad spectrum antibiotic medication used to treat respiratory and lung infections. Tequin carries risks of adverse side effects altering blood glucose levels, such as hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar). Both conditions can lead to coma or seizure and are are potentially fatal.

Read more on our Tequin Information Page >>

Zelnorm

Heart Attack • Stroke

Zelnorm is a serotonin agonist used for short term treatment of irritable bowel syndrome (IBS) with constipation. It was withdrawn from the market in April 2007 at FDA request because clinical trial data showed a link to heart attacks and strokes.

Read more on our Zelnorm Information Page >>

Bextra

Stevens-Johnson Syndrome • Heart Attack • Stroke

Bextra (valdecoxib) is a pain pill that is very similar to Vioxx; both are in the COX-2 inhibitor class of drugs. In addition to causing heart attacks, strokes, and other cardiovascular health problems, Bextra use has been linked to the potentially fatal skin conditions Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Bextra was withdrawn from the market in April 2005.

Read more on our Bextra Information Page >>

Crestor

Rhabdomyolysis • Kidney Failure

Crestor (rosuvastatin) is a statin drug used to lower cholesterol. Like the recalled drug Baycol, Crestor has been associated with rhabdomyolysis, a rare form of muscle toxicity. Unique to Crestor is its potential to cause kidney damage.

Read more on our Crestor Information Page >>

Vioxx

Heart Attack • Stroke • Sudden Death

Vioxx (rofecoxib) is a pain medication widely used until it was removed from the market in September 2004 because it was associated with increased cardiovascular risks including myocardial infarction (MI) or heart attack, ischemic stroke (CVA), and sudden cardiac death.

Read more on our Vioxx Information Page >>

Drug Injury Watch Blog


Read Tom Lamb's blog, at DrugInjuryWatch.com, providing news articles relating to prescription drug side effects, drug safety alerts, FDA recall notices, and legal case updates.

  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • DrugInjuryLaw.com is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535
email: ThomasJLamb@DrugInjuryLaw.com

Disclaimer